Represents percentage of cost of revenue.

No definition available.

Name:	rad_PercentageOfCostOfSales
Namespace Prefix:	rad_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents percentage of sales service revenue.

+ References

No definition available.

+ Details

Name:	rad_PercentageOfSalesServiceRevenue
Namespace Prefix:	rad_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Percentage points added to the reference rate to compute the variable rate on the debt instrument.

+ References

No definition available.

+ Details

Name:	us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Face (par) amount of debt instrument at time of issuance.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

+ Details

Name:	us-gaap_DebtInstrumentFaceAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The number of derivative instruments of a particular group held by the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959

+ Details

Name:	us-gaap_DerivativeNumberOfInstrumentsHeld
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeNumberOfInstrumentsHeldAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Summary of Significant Accounting Policies - Significant Concentrations (Details) $ in Thousands			12 Months Ended
	Mar. 15, 2019 USD ($)	Mar. 15, 2018	Mar. 02, 2019 USD ($) derivative	Mar. 03, 2018 USD ($) derivative	Mar. 04, 2017 USD ($)
Derivatives
Number of interest rate swap arrangements or other derivatives held \| derivative			0	0
Interest rate cap
Derivatives
Principal amount of debt	$ 650,000
Interest rate cap \| LIBOR
Derivatives
Interest rate	2.75%	2.75%
Retail Pharmacy \| Pharmacy sales \| Customers \| Top five third party payors
Significant Concentrations
Percentage of concentration risk			80.40%
Retail Pharmacy \| Pharmacy sales \| Customers \| Largest third party payor \| Express Scripts
Significant Concentrations
Percentage of concentration risk					26.00%
Retail Pharmacy \| Pharmacy sales \| Customers \| Largest third party payor \| Caremark
Significant Concentrations
Percentage of concentration risk			28.30%	27.20%
Retail Pharmacy \| Pharmacy sales \| Customers \| Medicaid agencies and related managed care Medicaid payors
Significant Concentrations
Percentage of concentration risk			19.10%
Retail Pharmacy \| Pharmacy sales \| Customers \| Largest Medicaid agency
Significant Concentrations
Percentage of concentration risk			1.80%
Retail Pharmacy \| Pharmacy sales \| Customers \| Medicare Part D
Significant Concentrations
Percentage of concentration risk			35.80%
Retail Pharmacy \| Purchases \| Suppliers \| McKesson Corp.
Significant Concentrations
Percentage of concentration risk			99.00%
Pharmacy Services \| Medicare Part D
Significant Concentrations
Percentage of revenues			1.80%	1.00%	1.00%
Derivatives
Net revenues			$ 391,024	$ 203,361	$ 223,077
Pharmacy Services \| Medicare Part D \| Swiss Re
Significant Concentrations
Percentage of revenues			50.00%
Percentage of cost of revenue			50.00%